The largest database of trusted experimental protocols

Brdu colorimetric assay kit

Manufactured by Roche
Sourced in United States

The BrdU colorimetric assay kit is a lab equipment product from Roche. It is used to measure cell proliferation by detecting the incorporation of the nucleoside analog bromodeoxyuridine (BrdU) into the DNA of proliferating cells.

Automatically generated - may contain errors

8 protocols using brdu colorimetric assay kit

1

Assessing Cell Proliferation with MG-132

Check if the same lab product or an alternative is used in the 5 most similar protocols
STHdh Q7/7or STHdh Q111/111 cells (6 × 103/well) were cultured for 24 h into 96-well plates before addition of MG-132 at the indicated concentration and cultured for additional 24 h at 37 °C. Cell proliferation was evaluated by measuring BrdU incorporation into DNA (BrdU colorimetric assay kit; Roche Applied Science, South San Francisco, CA, USA). Newly synthesized BrdU-DNA was determined by an ELISA plate reader (ThermoScientific) at 450 nm. All experiments were performed in triplicate, and the relative cell growth was expressed as a percentage in comparison with the untreated control cells (100%).
+ Open protocol
+ Expand
2

Evaluating Anti-proliferative Effects of SR141716 on Glioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glioma cells or normal human astrocytes (NHA) (4 × 103/well), were cultured for 24 h into 96-well plates before addition of SR141716 at the indicated concentrations and cultured for additional 72 h at 37°C. Cell proliferation was evaluated by measuring BrdU incorporation into DNA (BrdU colorimetric assay kit; Roche Applied Science, South San Francisco, CA, USA). Newly synthesized BrdU-DNA was determined on an ELISA plate reader (ThermoScientific) at 450 nm. All experiments were performed in triplicate, and the relative cell growth was expressed as a percentage comparison with the untreated control cells.
+ Open protocol
+ Expand
3

Proliferation and Migration Assays for Colon Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation in the colon cancer cell lines was analysed by measuring bromodeoxyuridine (BrdU) incorporation using the cell proliferation enzyme‐linked immunosorbent assay BrdU colorimetric assay kit (11647229001, Roche Applied Science, Upper Bavaria, Germany). Both serum‐ and glucose‐free culture medium was used to evaluate cell proliferation.
Cell migration and invasion assays were performed in accordance with the manufacturer's instructions (BD Biosciences, Franklin Lakes, NJ), as previously described.20
+ Open protocol
+ Expand
4

Evaluating HUVEC cell proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVEC cells (7 × 103/well), were cultured into 96-well plates for 24 h before the addition of HT at the indicated concentrations and cultured for additional 24–48 h at 37 °C. Cell proliferation was evaluated by measuring BrdU incorporation into DNA (BrdU colorimetric assay kit; Roche Applied Science, South San Francisco, CA, USA), by an ELISA plate reader (Thermo Scientific, Waltham, MA, USA) at 450 nm, as described in detail elsewhere [65 (link)]. In all experiments, performed in triplicate, the relative cell growth was expressed as percentage in comparison with untreated 24 h control cells (100%).
+ Open protocol
+ Expand
5

HT-Induced Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HaCaT cells (6 × 103/well) were cultured for 24 h into 96-well plates before the addition of HT at the indicated concentrations and were cultured for an additional 24–48 h at 37 °C. BrdU incorporation into DNA (BrdU colorimetric assay kit; Roche Applied Science, South San Francisco, CA, USA) was used to measure cell proliferation, determined by an ELISA (enzyme-linked immunosorbent assay) plate reader (ThermoScientific, Waltham, MA, USA) at 450 nm as described in detail elsewhere [68 (link)]. All experiments were performed in triplicate, and the relative cell growth was expressed as a percentage in comparison with the untreated control cells.
+ Open protocol
+ Expand
6

Evaluating U87-MG Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
U87-MG cell proliferation was evaluated by measuring BrdU incorporation into DNA (BrdU colorimetric assay kit; Roche Applied Science, South San Francisco, CA, USA) following treatment with temozolomide (100 μM) combined with increasing doses of LAV-BPIFB4 (0–144 ng/mL) for 96 h or following treatment with LAV-BPIFB4 at 18 ng/mL without temozolomide. Newly synthesized BrdU-DNA was determined on an ELISA plate reader (Thermo Scientific, Waltham, MA, USA) at 450 nm. All experiments were performed in triplicate, and the relative cell growth was expressed as a percentage of the untreated control cells (set to 100%) to allow for an unwanted source of variation.
+ Open protocol
+ Expand
7

Antiproliferative Effects of Ganoderma lucidum

Check if the same lab product or an alternative is used in the 5 most similar protocols
HaCaT cells (6 × 103/well) were cultured for 24 h into 96-well plates before the addition of the G. lucidum ethanol extract or ganoderic acid-A at the indicated concentrations and were cultured for an additional 24–48 h at 37 °C. Cell proliferation was evaluated by measuring BrdU incorporation into DNA (BrdU colorimetric assay kit; Roche Applied Science, South San Francisco, CA, USA) and was determined by an ELISA plate reader (ThermoScientific, Waltham, MA, USA) at 450 nm as described in detail elsewhere [43 (link)]. All experiments were performed in triplicate, and the relative cell growth was expressed as percentage in comparison with the untreated control cells (100%).
+ Open protocol
+ Expand
8

Endothelial Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro, endothelial cell proliferation was assessed by BrdU colorimetric assay kit (Roche Applied Science, Indianapolis, IN) according to the manufacturer’s protocol. Cells were plated in density 5000 cells/well in 96-well plate and kept overnight in complete medium. The cells were serum starved, exposed to 2-hour OGD. Upon reoxygenation, cells were treated with candesartan (0.1, 1 or 10 μg/ml), minocycline (6 μg/ml) or the combination of minocycline and different concentrations of candesartan. The BrdU labeling solution was then added. At 24 hours, absorbance was measured colorimetrically at 450 nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!